Synthesis,ABTS-Radical Scavenging Activity,and Antiproliferative and Molecular Docking Studies of Novel Pyrrolo[1,2-a]quinoline Derivatives

A new 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)-radical scavenging and antiproliferative agents of pyrrolo[1,2-a]quinoline derivatives have been synthesized. An efficient method for the synthesis of 14 novel diversified pyrrolo[1,2-a]quinoline derivatives has been described using 4-(1,3-dioxolan-2-yl)quinoline and different phenacyl bromides in acetone and followed by reacting with different acetylenes in dimethylformamide/K₂CO₃. The structure of the newly synthesized compounds was determined by infrared, ¹H NMR, ¹³C NMR, mass spectrometry, and elemental analysis. The in vitro antioxidant activity revealed that among all the tested compounds 5n exhibited maximum scavenging activity with ABTS. Compound 5b has showed good antiproliferative activity as an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.     

Nitrostyrene Derivatives of Adenosine 5′-Glutarates Modified with an Alkyl Spacer and their inhibitory activity on epidermal growth factor receptor protein tyrosine kinase

β-Nitrostyrene derivatives of adenosine 5′-glutarates are potent and selective bisubstrate-type inhibitors of the epidermal growth factor receptor protein tyrosine kinase (EGF-R PTK). In an attempt to improve the inhibitory activity, this type of compounds was modified with alkyl spacers of varying length between the nitrostyrene and the glutaryl units. The spacers consisted of 1, 3, 4, and 5 atoms to give compounds of the benzyl, oxyethyl, oxypropyl, and oxybutyl series, respectively (Schemes 1 and 2). Adenosine 5′-esters were prepared in the benzyl and oxypropyl series only. Compared to the compounds in the parent series without spacer (IC₅₀ = 0.7–12 μM ), most of the modified compounds inhibited the EGF-R PTK only marginally or were inactive (IC₅₀ ≥ 100 μM ). The only exceptions were the free acids 19 and 20 with IC₅₀ values of ca. 5 μM . It is noteworthy that esterification of these two hydrogen glutarates with either MeOH or adenosine yielded inactive compounds, which is in contrast to the corresponding substances without spacers.     

Synthesis of Firefly Luciferin Analogues and Evaluation of the Luminescent Properties

Five new firefly luciferin ( 1 ) analogues were synthesized and their light emission properties were examined. Modifications of the thiazoline moiety in 1 were employed to produce analogues containing acyclic amino acid side chains ( 2 – 4 ) and heterocyclic rings derived from amino acids ( 5 and 6 ) linked to the benzothiazole moiety. Although methyl esters of all of the synthetic derivatives exhibited chemiluminescence activity, only carboluciferin ( 6 ), possessing a pyrroline‐substituted benzothiazole structure, had bioluminescence (BL) activity (λ_max=547 nm). Results of bioluminescence studies with AMP‐carboluciferin (AMP=adenosine monophosphate) and AMP‐firefly luciferin showed that the nature of the thiazoline mimicking moiety affected the adenylation step of the luciferin–luciferase reaction required for production of potent BL. In addition, BL of 6 in living mice differed from that of 1 in that its luminescence decay rate was slower.     

Synthesis and anticancer activity of benzotriazole derivatives

A series of benzotriazole (BTA) derivatives were synthesized as tyrosine protein kinase inhibitors using fragment-based design strategy. All desired compounds were synthesized with the reaction of benzotriazole, chloroacetonitrile and aromatic aldehyde using Ultrasonic-Microwave method and characterized by IR, ¹H and ¹³C-NMR, mass spectrometry (MS) and elemental analysis. The anticancer activity of these compounds was evaluated by CCK-8 method against carcinoma VX2, lung cancer A549, stomach cancer cell lines MKN45 and MGC in vitro. The results showed that all compounds showed good antiproliferative activity. In particular, compound 2.1 showed the most prominent inhibition of VX2 cell lines with IC₅₀ of 3.80 ± 0.75 μM. Compound 2.2 exhibited highly potent anticancer activity of stomach MGC cell lines with IC₅₀ of 3.72 ± 0.11 μM. A549 and MKN45 cell lines were sensitive to compound 2.5 with IC₅₀ of 5.47 ± 1.11 and 3.04 ± 0.02 μM, respectively.     

Uses of cyclohexan-1,3-dione for the synthesis of tetrahydrochromeno[3,4-c]chromen derivatives with anti-tumor activities

Cyclohexan-1,3-dione ( 1 ) was used as the key starting material, which reacted with salicylaldehyde ( 2 ) and either malononitrile ( 3a ) or ethyl cyanoacetate ( 3b ) in ethanol containing a catalytic amount of triethylamine to give the 3,4,7,12b-tetrahydrochromeno[3,4-c]chromen-1-one derivatives 5a , b . The latter compounds underwent Gewald's thiophene synthesis through the reaction with either malononitrile or ethyl cyanoacetate to give compounds 6a-d , respectively. On the other hand, compound 5a was used for the synthesis of annulated chromeno[3,4-c]chromen derivatives through its reaction with different chemical reagents. The synthesized compounds were evaluated against the six cancer cell lines A549, HT-29, MKN-45, U87MG, SMMC-7721, and H460 using the standard MTT assay in vitro, with foretinib as the positive control, many compounds expressed high inhibitions. The most active compounds 5b , 6b , 6d , 7 , 9b , 11a , 11b , 13 , 17 , 18b , 20b , 21b , 21e , and 21f were selected for inhibition of five tyrosine kinases and some selected compounds for Pim-1 kinase inhibition. The results showed that compounds 6b , 6d , 11a , 13 , 17 , 20b , and 21e were the most potent compounds with the tyrosine kinases and compounds 6d , 11a , 20b , and 21e were the most potent inhibitors of Pim-1 kinase.     

Reaktionsverhalten tricyclischer 4H,8H-Benzo[1,2-c:4,5-c′]-diisoxazol-4,8-dione gegenüber Reduktionsmitteln

Reaction Behavior of 4H,8H-Benzo[1,2-c:4,5-c′]diisoxazole-4,8-dionos towards Reducing Agents By reduction of the 3,7-diamino-substituted heterocycles 1c – d and 6a – d , the quinoid 2,5-diamino-3,6-dioxo-cyclohexa- 1,4-diene- 1,4-dicarboxamides 2c – h and 7a – d are synthesized. The diaminodicarboxamides 2 can be recyclised by use of Pb(AcO)₄. The dialkylamino-substituted derivatives 1c – h react with NaBH₄ under conservation of the heterocyclic system to the tetrahydro-benzo[1,2-c:4,5-c′] diisoxazoldiones of type 5 . The NMR-spectroscopic behavior of 2 and 7 is discussed.     

Design,synthesis, anticancer activity,and in silico studies of novel imidazo[1,2-a]pyridine based 1H-1,2,3-triazole derivatives

A novel series of imidazo[1,2-a]pyridine based 1H-1,2,3-triazole derivatives were designed, synthesized, and evaluated for their anticancer activity against two different human cancer cell lines. Most of the synthesized compounds displayed anticancer activity with IC₅₀ values from 2.35 to 120.46 μM. Furthermore, compounds 9b , 9c, 9d, 9f , and 9j showed potent inhibitory activity against cancer cell lines, with IC₅₀ values close to that of standard drug. It is important to note that compound 9d was more potent than the standard drug cisplatin with IC₅₀ values of 10.89 and 2.35 μM against Hela cell line and MCF-7 cell line, respectively.     

Electron ionization mass spectra of novel 2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose derivatives and related sugar sulfamates

The electron-impact (EI) mass spectral fragmentation of ten bis-O- (1-methylethylidene)fructopyranose derivatives and three related sugar sulfamates were investigated. In particular, 2,3:4,5-bis-O - (1-methylethylidene)-β-D-fructopyranose sulfamate (topiramate), a potent anticonvulsant, was examined in greater detail. The fragmentation of the 2,3:4,5-bis-O-(1-methylethylidene) fructopyranose derivatives in general was not very dependent on the nature of substitution; the mechanisms of the common and unique fragmentation patterns are presented. These compounds showed characteristic peaks at m/z [M – 15]⁺, [M – 15 – 58]⁺, [M – 15 – 58 – 60]⁺, [M ? CH₂X]⁺ and [M ? CH₂X – 58]⁺ where X = OSO₂NR₂ (R ? H, CH₃, and/or Ph), OC (O)NHR, NH₂, CI and OH. The fragmentation of isomeric bis-O-(1-methylethylidene) derivatives of aldopyranose, ketopyranose and ketofuranose sulfamates was also investigated. The results indicate that isomeric sugar sulfamates can be easily distinguished in the EI mode. Key fragmentation pathways are discussed for these compounds.     

1,2,3-Triazolo[4,5-e]-1,2,4-triazolo[3,4-c]pyrimidines

Some new 1,2,3-triazolo[4,5-e]-1,2,4-triazolo[3, 4 -c]pyrimidmes were prepared starting from the corresponding 1,2,3-triazolo[4,5-d]pyrimidines via the formation of the 1,2,4-triazole ring. Thus suitable hydrazino derivatives 6 were condensed with triethyl orthoformate, triethyl orthoacetate and triethyl orthobenzoate to give the expected tricyclic derivatives 7 , 8 and 9 . Intramolecular cyclization of the ethoxycarbonylhydrazino derivatives 10 gave the tricyclic compounds 11 bearing an hydroxyl group in the 3 position. The v-triazolo-s-triazolopyrimidine derivatives were tested towards the A₁ and A_2A adenosine receptors in binding assays, but they did not show any receptor affinity.     

Synthesis of novel [1,2,3]triazolo[4′,5′:3,4]pyrrolo[1,2-a]thieno[2,3-d] pyrimidines: Potent EGFR targeting anti-breast cancer agents

In this study, we designed and synthesized several novel fused [1,2,3]triazolo [4′,5′:3,4]pyrrolo[1,2-a]thieno[2,3-d]pyrimidine derivatives using in a single [3 + 2] reaction cycloaddition reaction of 3-(3-iodoprop-2-yn-1-yl)thieno[2,3-d]pyrimidin-4(3H)-one ( 4 ) followed by C-C bond coupling with various aryl azides in a PEG-400 medium. All of the newly synthesized compounds were evaluated in vitro for EGFR kinase inhibitory action as well as anti-breast cancer activity against MDA-MB-231 and MCF-7 breast cancer cell lines. When compared to the reference molecule, erlotinib, the majority of the compounds demonstrated adequate efficacy. The most promising compounds, 5g and 5i , demonstrated excellent anticancer activity against both cancer cell lines, with IC₅₀ values ranging from 04.17 ± 0.55 to 8.65 ± 0.89 μM, respectively, as well as excellent kinase inhibitory activities (EGFR: IC₅₀ = 0.467 ± 0.063 and 0.412 ± 0.081 μM). The in silico studies of five potent compounds 5f , 5g , 5h , 5i , and 5k were also carried out to identify the interactions against the EGFR receptor and found that the energy calculations were covenant with the obtained IC₅₀ values.     

Mesoionic isoxazolo[2,3-a]pyrimidinediones and 1,3,4-oxadiazolo[3,2-a]pyrimidinediones as potential adenosine antagonists

Several derivatives of two novel mesoionic ring systems, i.e., isoxazolo[2,3-a]pyrimidinedione and 1,3,4-oxadiazolo[3,2-a]pyrimidinedione, were prepared for evaluation as adenosine antagonists. Whereas both ring systems are relatively stable when the 6-position (i.e., that position corresponding to the purine 1-position) is substituted by an alkyl group, neither ring system is stable when this position is unsubstituted. An example of a 6-unsubstituted non-mesoionic isoxazolopyrimidinedione exhibited similar behavior. As adenosine antagonists, the mesoionic compounds were found to be less potent than their previously evaluated mesoionic thiadiazolo[3,2-a]pyrimidinedione counterparts.     

Imidazopyridazine Acetylcholinesterase Inhibitors Display Potent Anti-Proliferative Effects in the Human Neuroblastoma Cell-Line,IMR-32

Imidazo[1,2-b]pyridazine compounds are a new class of promising lead molecules to which we have incorporated polar nitro and amino moieties to increase the scope of their biological activity. Two of these substituted 3-nitro-6-amino-imidazo[1,2-b]pyridazine compounds (5c and 5h) showed potent acetylcholinesterase (AChE) inhibitory activity (IC₅₀ 40–50 nM), which we have previously reported. In this study, we wanted to test the biological efficacy of these compounds. Cytotoxicity assays showed that compound 5h mediated greater cell death with over 43% of cells dead at 100 μM and activation of caspase 3-mediated apoptosis. On the other hand, compound 5c mediated a dose-dependent decrease in cell proliferation. Both compounds showed cell cycle arrest in the G₀/G₁ phase and reduced cellular ATP levels leading to activation of adenosine monophosphate-activated protein kinase (AMPK) and enhanced mitochondrial oxidative stress. It has to be noted that all these effects were observed at doses beyond 10 μM, 200-fold above the IC₅₀ for AChE inhibition. Both compounds also inhibited bacterial lipopolysaccharide-mediated cyclooxygenase-2 and nitric oxide release in primary rat microglial cells. These results suggested that the substituted imidazo (1,2-b) pyridazine compounds, which have potent AChE inhibitory activity, were also capable of antiproliferative, anti-migratory, and anti-inflammatory effects at higher doses.     

Synthesis and Adenosine Deaminase Inhibitory Activity of 3′-Deoxy-1-deazaadenosines

New 1-deazapurine nucleosides were synthesized by coupling 2,6-dichloro-1-deaza-9H-purine (=5,7-dichloro-3H-imidazo[4,5-b]pyridine) with a 3-deoxyribose derivative by the acid-catalyzed fusion method. The condensation reaction gave an anomeric mixture of the N⁹-β-D - and N⁹-α-D -3′-deoxynucleosides, which were treated with methanolic ammonia at room temperature to obtain the deprotected derivatives. Reaction of the β-D -anomer with different amines gave 2-chloro-N⁶-substituted nucleosides, which were dechlorinated to give the corresponding 3′-deoxy-1-deazaadenosines. Biological studies on adenosine deaminase from calf intestine showed that the new compounds are inhibitors of the enzyme, the 3′-deoxy-1-deazaadenosine being the most potent one with a K_i of 2.6 μM .     

Synthesis of Modified Tripeptides and Tetrapeptides as potential bisubstrate inhibitors of the epidermal growth factor receptor protein tyrosine kinase

The synthesis of a series of bisubstrate inhibitors of the epidermal growth factor receptor protein kinase (EGF-R PTK) consisting of small pep tides linked covalently to adenosine via appropriate triphosphate substitutes is described. Boc-Glu(O^tBu)-Tyr-Leu-OBzl ( 5 ) and Ac-Glu(O^tBu)-Tyr-Leu-Arg(Pmc)-NH₂ ( 8 ; Pmc = 2,2,5,7,8-pentamethylchroman-6-sulfonyl) were prepared by standard peptide chemistry, (Scheme 1), then modified at the OH group of tyrosine either with adipic anhydride or with 4-(chlorosulfonyl)benzoic acid, 4-(chlorosulfonyl)-2-hydroxybenzoic acid, or benzene-1,4-disulfonyldichloride (Scheme 2), and finally coupled with the 5′-OH group of 2′,3′-O-isopropylideneadenosine (Scheme 3). In addition, N⁶-[(benzyloxy)carbonyl]-2′,3′-O-isopropylidene-adenosine 5′-(hydrogenhexanedioate) ( 26 ), an ATP substitute, was coupled with the morpholide of 5 (Scheme 4). Removal of the protecting groups gave the bisubstrate analogs 23, 24 , and 28. The compounds synthesized were tested as inhibitors of the EGF-R PTK. The most active bisubstrate-type inhibitor was 24 , composed of the tripeptide sequence H-Glu-Tyr-Leu-OBzl, the 2-hydroxy-4-sulfonylbenzoyl moiety, and adenosine; it showed an IC₅₀ value of 33 μM.     

Design and Synthesis of Some Novel 2,3,4,5‐Tetrahydro‐1H‐pyrido[4,3‐b]indoles as Potential c‐Met Inhibitors

Since deregulation of the tyrosine‐kinase receptor c‐Met is implicated in several human cancers and is an attractive target for small‐molecule‐drug discovery, we report herein the synthesis of 2,3,4,5‐tetrahydro‐8‐[1‐(quinolin‐6‐ylmethyl)‐1H‐1,2,3‐triazolo[4,5‐b]pyrazin‐6‐yl]‐1H‐pyrido[4,3‐b]indoles 4a – 4c and 2,3,4,5‐tetrahydro‐8‐[3‐(quinolin‐6‐ylmethyl)‐1,2,4‐triazolo[4,3‐b]pyridazin‐6‐yl]‐1H‐pyrido[4,3‐b]indoles 5a – 5c . These indole derivatives demonstrated inhibition of c‐Met kinase activity. Concurrently, five key intermediates were synthesized. These compounds could be prepared in good yields.     

Probing the role of the linker in ferrocene-ATP conjugates: monitoring protein kinase catalyzed phosphorylations electrochemically

The synthesis and electrochemical properties of ferrocene conjugates are presented for the purpose of investigating adenosine 5′‐[γ‐ferrocenoylalkyl] triphosphate ( 1 a – 4 a , ferrocene (Fc)–ATP) as co‐substrates for phosphorylation reactions. Compounds 1 a – 4 a were synthesized, purified by HPLC, and characterized by NMR spectroscopy and mass spectrometry. In solution, all Fc–ATP bioconjugates exhibit a reversible one‐electron redox process with a half‐wave potential (E_1/2) in the 390–430 mV range, peak separations (ΔE_p) in the 40–70 mV range, and the peak current ratio (i_pa/i_pc) near unity. The peptide‐modified surface Glu‐Gly‐Ile‐Tyr‐Asp‐Val‐Pro was used to study the sarcoma‐related protein (Src) kinase activity by employing the Fc–ATP bioconjugates as co‐substrates. Subsequent kinase‐catalyzed transfer of the γ‐Fc‐phosphate group to the tyrosine residues of the surface‐bound peptides was characterized by a formal potential (E^o) ≈390 mV (vs. Ag/AgCl). The Fc‐coverage, estimated by time‐of‐flight secondary‐ion mass spectrometry (TOF‐SIMS) and cyclic voltammetry (CV), suggested validity of Fc–ATP conjugates as kinase co‐substrates. Depending on the length of the alkyl spacer of the Fc–ATP conjugate, different current densities were obtained, pointing to a direct correlation between the two. Molecular modeling revealed that the structural constraint imposed by the short alkyl spacer ( 1 a ) causes a steric congestion and negatively affects the outcome of phosphorylation reaction. An optimal analytical response was obtained with the Fc–ATP conjugates with linker lengths longer than six CH₂ groups.     

Synthesis of benzimidazole derivatives as potential H1-antihistaminic agents

Several types of benzimidazole derivatives were prepared and were screened for H ₁-antihistaminic activity. Most of the compounds showed potent antihistaminic activity in vitro. Among them 2-[(1-piperazinyl)methyl]-benzimidazoles 14 and 2-[(1-homopiperazinyi)methyl]benzimidazoles 15 exhibited potent activity also in vivo.     

Synthesis,Docking, and Pharmacological Evaluation of Derivatives of α‐Aminoketones Appended to Sydnones as Potent Antitubercular and Antifungal Scaffolds

3‐Arylsydnones are reported to possess striking pharmaceutical potency. α‐Aminoketone, a biologically active structural unit, is built at the fourth (electrophilic) position of sydnone and further derivatized with secondary amine and tetrazoles. The α‐aminoketone derivatives of sydnones coupled with secondary amines 4a – n were docked on enoyl acyl carrier protein (ACP) reductase from Mycobacterium tuberculosis, which revealed that compounds 4b , 4f , and 4i showed efficient C score values with different binding modes and hydrogen bonding. Further, these compounds were screened for antimycobacterial activity; among them, compound 4f displayed sensitivity at 6.25 μg/mL compared with the standard drug (Streptomycin) against M. tuberculosis (H₃₇R_V strain). In addition to this, α‐aminoketone derivatives of sydnones coupled with tetrazoles 8a – h were evaluated for antifungal activity. In the antifungal activity, compound 8b has exhibited potent activity at 6.25 μg/mL against Candida albicans and compound 8g at 0.4 μg/mL against Aspergillus fumigatus. The antifungal activities are comparatively better than standard antifungal agent Fluconazole at these drug concentrations. Alongside characterization of the final compounds by Fourier transform infrared, mass, ¹H NMR, and ¹³C NMR spectral analyses, compounds 8b and 8g were confirmed by X‐ray crystallographic studies.     

Synthesis of C12-Keto Saxitoxin Derivatives with Unusual Inhibitory Activity Against Voltage-Gated Sodium Channels

A novel series of C12-keto-type saxitoxin (STX) derivatives bearing an unusual nonhydrated form of the ketone at C12 has been synthesized, and their Na_V-inhibitory activity has been evaluated in a cell-based assay as well as whole-cell patch-clamp recording. Among these compounds, 11-benzylidene STX ( 3 a ) showed potent inhibitory activity against neuroblastoma Neuro 2A in both cell-based and electrophysiological analyses, with EC₅₀ and IC₅₀ values of 8.5 and 30.7 nm , respectively. Interestingly, the compound showed potent inhibitory activity against tetrodotoxin-resistant subtype of Na_V1.5, with an IC₅₀ value of 94.1 nm . Derivatives 3 a – d and 3 f showed low recovery rates from Na_V1.2 subtype (ca 45–79 %) compared to natural dcSTX ( 2 ), strongly suggesting an irreversible mode of interaction. We propose an interaction model for the C12-keto derivatives with Na_V in which the enone moiety in the STX derivatives 3 works as Michael acceptor for the carboxylate of Asp¹⁷¹⁷.